Search hospitals > Louisiana > Marrero
Tandem Clinical Research
Claim this profileMarrero, Louisiana 70072
Global Leader in Non-alcoholic Fatty Liver Disease
Global Leader in Fatty Liver Disease
Conducts research for Liver Disease
Conducts research for Liver Cirrhosis
Conducts research for Obesity
99 reported clinical trials
4 medical researchers
Summary
Tandem Clinical Research is a medical facility located in Marrero, Louisiana. This center is recognized for care of Non-alcoholic Fatty Liver Disease, Fatty Liver Disease, Liver Disease, Liver Cirrhosis, Obesity and other specialties. Tandem Clinical Research is involved with conducting 99 clinical trials across 92 conditions. There are 4 research doctors associated with this hospital, such as Gary Reiss, MD, Adil Fatakia, MD, Lincoln Hernandez, MD, and Angela Traylor, MD.Area of expertise
1Non-alcoholic Fatty Liver Disease
Global LeaderStage I
Stage II
2Fatty Liver Disease
Global LeaderStage I
Stage II
Top PIs
Gary Reiss, MDTandem Clinical Research3 years of reported clinical research
Studies Non-alcoholic Fatty Liver Disease
Studies Fatty Liver Disease
18 reported clinical trials
20 drugs studied
Adil Fatakia, MDTandem Clinical Research3 years of reported clinical research
Studies Obesity
Studies Non-alcoholic Fatty Liver Disease
14 reported clinical trials
22 drugs studied
Lincoln Hernandez, MDTandem Clinical Research, LLC3 years of reported clinical research
Studies Non-alcoholic Fatty Liver Disease
Studies Fatty Liver Disease
3 reported clinical trials
6 drugs studied
Angela Traylor, MDTandem Clinical Research, Marrero1 year of reported clinical research
Studies Dementia
Studies Lewy Body Disease
1 reported clinical trial
1 drug studied
Clinical Trials running at Tandem Clinical Research
Non-alcoholic Fatty Liver Disease
Type 2 Diabetes
Crohn's Disease
Fatty Liver Disease
Ulcerative Colitis
Osteoarthritis
Depression
Diabetes
Pathologic Constriction
Major Depressive Disorder
Resmetirom
for Fatty Liver Disease
This study is evaluating whether a drug may help treat nonalcoholic steatohepatitis (NASH).
Recruiting1 award Phase 36 criteria
Lanifibranor
for Nonalcoholic Steatohepatitis (NASH)
This study is evaluating whether a drug called lanifibranor can improve liver health in people with nonalcoholic steatohepatitis.
Recruiting1 award Phase 31 criteria
HU6
for Type 2 Diabetes with Risk of Fatty Liver Disease
This is a phase 2 randomized, double-blind, placebo-controlled parallel group study of 3 dose levels of HU6 in obese subjects with type 2 diabetes (T2D) at risk of nonalcoholic steatohepatitis (NASH). Six months (26 weeks) of dosing is planned, and subjects will be followed for safety, efficacy, pharmacodynamics (PD), and pharmacokinetics (PK) during this time. The end-of-study visit will take place approximately 4 weeks after the last dose of the study drug (Week 30).
Recruiting0 awards Phase 27 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Tandem Clinical Research?
Tandem Clinical Research is a medical facility located in Marrero, Louisiana. This center is recognized for care of Non-alcoholic Fatty Liver Disease, Fatty Liver Disease, Liver Disease, Liver Cirrhosis, Obesity and other specialties. Tandem Clinical Research is involved with conducting 99 clinical trials across 92 conditions. There are 4 research doctors associated with this hospital, such as Gary Reiss, MD, Adil Fatakia, MD, Lincoln Hernandez, MD, and Angela Traylor, MD.